Dan Robins

Dan Robins is a board member at ZeoVation, a company that specializes in zeolite-based products. Prior to their current position, Dan was the Vice President of Global Development at Mylan Pharmaceuticals from September 2010 to September 2012. In this role, Dan was responsible for coordinating global injectable R&D at three R&D centers located in Ireland, India, and the United States. Dan also worked closely with the VP of global commercial strategy on portfolio optimization and assisted with the technical and regulatory review of all injectable acquisition, licensing, and co-development opportunities. In addition, Dan managed an expense budget of $20 million (direct) and $50 million (indirect), and worked with corporate manufacturing on a sterile facility expansion capital plan that totaled over $100 million. Dan's direct reports included the heads of injectable R&D at two sites, the R&D Project Sr. Manager, and the Director of External R&D Project Management and Technology Transfer. Their indirect reports included the Head of Global Regulatory Affairs, the Director of Quality, the Sr. Director of 3P Injectable Contract Manufacturing, the Head of Global Sourcing (API), and two VP and GM of sterile manufacturing sites located in Ireland and the United States.

Dan Robins has a degree in Chemistry from La Salle University, an MS and PhD in Analytical Chemistry from The Ohio State University, and an MBA in Management and Finance from NYU Stern School of Business. Dan also has a degree in Environmental Science from the University of Colorado Boulder.